Abstract
Background:Helicobacter pylori eradication is increasingly challenged, due to high antibiotic resistance rates in H. pylori and treatment failure. Consequently, new treatment regimens are needed. Probiotic and gastrointestinal bacteria exert anti-H. pylori activity in vivo, thus being potential add-on candidates for future eradication strategies. Summary: In this review, we summarised the currently available literature for in vivo inhibition of H. pylori. Included studies address anti-H. pylori effects in mouse and rat models caused by potentially beneficial bacteria. Research on literature was further extended to clinical eradication studies in humans. Several bacterial strains, mainly belonging to the Lactobacillus genus, inhibited H. pylori in vivo. In animal studies, probiotic bacteria and commensals reduced H. pylori colonisation and the inflammatory response. Certain probiotic species reduce H. pylori colonisation in humans. Key Messages: Probiotic and gastrointestinal commensals are beneficial in H. pylori eradication therapy. Their current role is the reduction of adverse events and H. pylori load.
References
1.
Sheh
A
, Fox
JG
. The role of the gastrointestinal microbiome in Helicobacter pylori pathogenesis
. Gut Microbes
. 2013
;4
(6
):505
–31
. 2.
Bik
EM
, Eckburg
PB
, Gill
SR
, Nelson
KE
, Purdom
EA
, Francois
F
, et al. Molecular analysis of the bacterial microbiota in the human stomach
. Proc Natl Acad Sci USA
. 2006
;103
(3
):732
–7
. 3.
Schulz
C
, Koch
N
, Schütte
K
, Pieper
DH
, Malfertheiner
P
. H. pylori and its modulation of gastrointestinal microbiota
. J Dig Dis
. 2015
;16
(3
):109
–17
. 4.
Lorca
GL
, Wadström
T
, Valdez
GFD
, Ljungh
A
. Lactobacillus acidophilus autolysins inhibit Helicobacter pylori in vitro
. Curr Microbiol
. 2001
;42
(1
):39
–44
. 5.
Cats
A
, Kuipers
EJ
, Bosschaert
MAR
, Pot
RGJ
, Vandenbroucke-Grauls
CMJE
, Kusters
JG
. Effect of frequent consumption of a Lactobacillus casei-containing milk drink in Helicobacter pylori-colonized subjects
. Aliment Pharmacol Ther
. 2003
;17
(3
):429
–35
. 6.
Liang
Y
, Yan
J
, Chen
Z
, Gu
Q
, Li
P
. Antibacterial effects of bacteriocin PLNC8 against Helicobacter pylori and its potential mechanism of action
. Foods
. 2022
;11
(9
):1235
. 7.
de Klerk
N
, Maudsdotter
L
, Gebreegziabher
H
, Saroj
SD
, Eriksson
B
, Eriksson
OS
, et al. Lactobacilli reduce Helicobacter pylori attachment to host gastric epithelial cells by inhibiting adhesion gene expression
. Infect Immun
. 2016
;84
(5
):1526
–35
. 8.
Okuda
K
, Ishihara
K
, Miura
T
, Katakura
A
, Noma
H
, Ebihara
Y
. Helicobacter pylori may have only a transient presence in the oral cavity and on the surface of oral cancer
. Microbiol Immunol
. 2000
;44
(5
):385
–8
. 9.
Ierardi
E
, Losurdo
G
, Mileti
A
, Paolillo
R
, Giorgio
F
, Principi
M
, et al. The puzzle of coccoid forms of Helicobacter pylori: beyond basic science
. Antibiotics
. 2020
;9
(6
):293
. (in eng). 10.
Nia
FF
, Ghasemi
A
, Saeidi
J
, Mohtashami
M
. Inhibitory activity of Limosilactobacillus reuteri isolated from camel milk against Helicobacter pylori effects in human gastric epithelial cells
. Biotechnol Appl Biochem
. 2023
;70
(6
):1941
–53
. 11.
Megraud
F
, Bruyndonckx
R
, Coenen
S
, Wittkop
L
, Huang
TD
, Hoebeke
M
, et al. Helicobacter pylori resistance to antibiotics in Europe in 2018 and its relationship to antibiotic consumption in the community
. Gut
. 2021
;70
(10
):1815
–22
. 12.
Westphal
JR
, Koch
N
, Macke
L
, Vasapolli
R
, Saka
D
, Vilchez-Vargas
R
, et al. Inhibitory effects of probiotic & gastro-intestinal bacteria on H. pylori in vitro
. Digestion
. 2025
:1
–30
. (in eng). 13.
Wang
K-Y
, Li
SN
, Liu
CS
, Perng
DS
, Su
YC
, Wu
DC
, et al. Effects of ingesting Lactobacillus- and Bifidobacterium-containing yogurt in subjects with colonized Helicobacter pylori
. Am J Clin Nutr
. 2004
;80
(3
):737
–41
. 14.
Linsalata
M
, Russo
F
, Berloco
P
, Caruso
ML
, Matteo
GDI
, Cifone
MG
, et al. The influence of Lactobacillus brevis on ornithine decarboxylase activity and polyamine profiles in Helicobacter pylori-infected gastric mucosa
. Helicobacter
. 2004
;9
(2
):165
–72
. 15.
Pantoflickova
D
, Corthésy-Theulaz
I
, Dorta
G
, Stolte
M
, Isler
P
, Rochat
F
, et al. Favourable effect of regular intake of fermented milk containing Lactobacillus johnsonii on Helicobacter pylori associated gastritis
. Aliment Pharmacol Ther
. 2003
;18
(8
):805
–13
. 16.
Chen
CC
, Liou
JM
, Lee
YC
, Hong
TC
, El-Omar
EM
, Wu
MS
. The interplay between Helicobacter pylori and gastrointestinal microbiota
. Gut Microbes
. 2021
;13
(1
):1
–22
. 17.
Cruchet
S
, Obregon
MC
, Salazar
G
, Diaz
E
, Gotteland
M
. Effect of the ingestion of a dietary product containing Lactobacillus johnsonii La1 on Helicobacter pylori colonization in children
. Nutrition
. 2003
;19
(9
):716
–21
. 18.
Wang
S
, Zhang
M
, Yu
L
, Tian
F
, Lu
W
, Wang
G
, et al. Evaluation of the potential protective effects of lactobacillus strains against Helicobacter pylori infection: a randomized, double-blinded, placebo-controlled trial
. Can J Infect Dis Med Microbiol
. 2022
;2022
:6432750
–13
. 19.
Rosania
R
, Minenna
MF
, Giorgio
F
, Facciorusso
A
, De Francesco
V
, Hassan
C
, et al. Probiotic multistrain treatment may eradicate Helicobacter pylori from the stomach of dyspeptics: a placebo-controlled pilot study
. Inflamm Allergy Drug Targets
. 2012
;11
(3
):244
–9
. 20.
Malfertheiner
P
, Megraud
F
, O’Morain
CA
, Gisbert
JP
, Kuipers
EJ
, Axon
AT
, et al. Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report
. Gut
. 2017
;66
(1
):6
–30
. 21.
Malfertheiner
P
, Megraud
F
, Rokkas
T
, Gisbert
JP
, Liou
JM
, Schulz
C
, et al. Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report
. Gut
. 2022
;71
(9
):1724
–62
. 22.
Probiotics in food health and nutritional properties and guidelines for evaluation
; 2006
. [Online]. Available from: https://www.fao.org/3/a0512e/a0512e.pdf23.
Dethlefsen
L
, Relman
DA
. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation
. Proc Natl Acad Sci USA
. 2011
;108
(Suppl 1
):4554
–61
. (in eng). 24.
Gill
HS
, Guarner
F
. Probiotics and human health: a clinical perspective
. Postgrad Med J
. 2004
;80
(947
):516
–26
. 25.
Fernández
MF
, Boris
S
, Barbés
C
. Probiotic properties of human lactobacilli strains to be used in the gastrointestinal tract
. J Appl Microbiol
. 2003
;94
(3
):449
–55
. 26.
Gotteland
M
, Andrews
M
, Toledo
M
, Muñoz
L
, Caceres
P
, Anziani
A
, et al. Modulation of Helicobacter pylori colonization with cranberry juice and Lactobacillus johnsonii La1 in children
. Nutrition
. 2008
;24
(5
):421
–6
. 27.
Salminen
S
, von Wright
A
, Morelli
L
, Marteau
P
, Brassart
D
, de Vos
WM
, et al. Demonstration of safety of probiotics: a review
. Int J Food Microbiol
. 1998
;44
(1–2
):93
–106
. 28.
Delorme
C
. Safety assessment of dairy microorganisms: Streptococcus thermophilus
. Int J Food Microbiol
. 2008
;126
(3
):274
–7
. 29.
Khosravi
Y
, Dieye
Y
, Loke
MF
, Goh
KL
, Vadivelu
J
. Streptococcus mitis induces conversion of Helicobacter pylori to coccoid cells during co-culture in vitro
. PLoS One
. 2014
;9
(11
):e112214
–11
. 30.
Liu
Y-W
, Liong
M-T
, Tsai
Y-C
. New perspectives of Lactobacillus plantarum as a probiotic: the gut-heart-brain axis
. J Microbiol
. 2018
;56
(9
):601
–13
. 31.
Snydman
DR
. The safety of probiotics
. Clin Infect Dis
. 2008
;46
(s2
):S104
–11
. 32.
Schulz
C
, Schütte
K
, Koch
N
, Vilchez-Vargas
R
, Wos-Oxley
ML
, Oxley
APA
, et al. The active bacterial assemblages of the upper GI tract in individuals with and without Helicobacter infection
. Gut
. 2018
;67
(2
):216
–25
. 33.
Kõll-Klais
P
, Mändar
R
, Leibur
E
, Marcotte
H
, Hammarström
L
, Mikelsaar
M
. Oral lactobacilli in chronic periodontitis and periodontal health: species composition and antimicrobial activity
. Oral Microbiol Immunol
. 2005
;20
(6
):354
–61
. 34.
Ahrné
S
, Nobaek
S
, Jeppsson
B
, Adlerberth
I
, Wold
AE
, Molin
G
. The normal Lactobacillus flora of healthy human rectal and oral mucosa
. J Appl Microbiol
. 1998
;85
(1
):88
–94
. 35.
Liljemark
WF
, Gibbons
RJ
. Proportional distribution and relative adherence of Streptococcus miteor (mitis) on various surfaces in the human oral cavity
. Infect Immun
. 1972
;6
(5
):852
–9
. 36.
Aiba
Y
, Nakano
Y
, Koga
Y
, Takahashi
K
, Komatsu
Y
. A highly acid‐resistant novel strain of Lactobacillus johnsonii No. 1088 has antibacterial activity, including that against Helicobacter pylori, and inhibits gastrin‐mediated acid production in mice
. MicrobiologyOpen
. 2015
;4
(3
):465
–74
. 37.
Sunanliganon
C
, Thong-Ngam
D
, Tumwasorn
S
, Klaikeaw
N
. Lactobacillus plantarum B7 inhibits Helicobacter pylori growth and attenuates gastric inflammation
. World J Gastroenterol
. 2012
;18
(20
):2472
–80
. 38.
Ryan
KA
, Daly
P
, Li
Y
, Hooton
C
, O’Toole
PW
. Strain-specific inhibition of Helicobacter pylori by Lactobacillus salivarius and other lactobacilli
. J Antimicrob Chemother
. 2008
;61
(4
):831
–4
. 39.
Zhang
L
, Su
P
, Henriksson
A
, O’Rourke
J
, Mitchell
H
. Investigation of the immunomodulatory effects of Lactobacillus casei and Bifidobacterium lactis on Helicobacter pylori infection
. Helicobacter
. 2008
;13
(3
):183
–90
. 40.
Johnson-Henry
KC
, Mitchell
DJ
, Avitzur
Y
, Galindo-Mata
E
, Jones
NL
, Sherman
PM
. Probiotics reduce bacterial colonization and gastric inflammation in H. pylori-infected mice
. Dig Dis Sci
. 2004
;49
(7–8
):1095
–102
. 41.
Cui
Y
, Wang
CL
, Liu
XW
, Wang
XH
, Chen
LL
, Zhao
X
, et al. Two stomach-originated lactobacillus strains improve Helicobacter pylori infected murine gastritis
. World J Gastroenterol
. 2010
;16
(4
):445
–52
. 42.
Chen
Y-H
, Tsai
WH
, Wu
HY
, Chen
CY
, Yeh
WL
, Chen
YH
, et al. Probiotic lactobacillus spp. act against Helicobacter pylori-induced inflammation
. J Clin Med
. 2019
;8
(1
):90
. 43.
Sgouras
D
, Maragkoudakis
P
, Petraki
K
, Martinez-Gonzalez
B
, Eriotou
E
, Michopoulos
S
, et al. In vitro and in vivo inhibition of Helicobacter pylori by Lactobacillus casei strain Shirota
. Appl Environ Microbiol
. 2004
;70
(1
):518
–26
. 44.
Lin
C-C
, Huang
WC
, Su
CH
, Lin
WD
, Wu
WT
, Yu
B
, et al. Effects of multi-strain probiotics on immune responses and metabolic balance in Helicobacter pylori-infected mice
. Nutrients
. 2020
;12
(8
):2476
. 45.
Sgouras
DN
, Panayotopoulou
EG
, Martinez-gonzalez
B
, Petraki
K
, Michopoulos
S
, Mentis
A
. Lactobacillus johnsonii La1 attenuates Helicobacter pylori -associated gastritis and reduces levels of proinflammatory chemokines in C57BL/6 mice
. Clin Diagn Lab Immunol
. 2005
;12
(12
):1378
–86
. 46.
Hsieh
PS
, Tsai
YC
, Chen
YC
, Teh
SF
, Ou
CM
, King
VAE
. Eradication of H Infection by the probiotic strains LMH‐68 and L ssp. salicinius AP‐32
. Helicobacter
. 2012
;17
(6
):466
–77
. 47.
Hong
S-S
, Lee
HA
, Kim
JY
, Jeong
JW
, Shim
JJ
, Lee
JL
, et al. In vitro and in vivo inhibition of Helicobacter pylori by Lactobacilllus paracasei HP7
. Lab Anim Res
. 2018
;34
(4
):216
–22
. 48.
Zhou
Q
, Qureshi
N
, Xue
B
, Xie
Z
, Li
P
, Gu
Q
. Preventive and therapeutic effect of Lactobacillus paracasei ZFM54 on Helicobacter pylori-induced gastritis by ameliorating inflammation and restoring gastric microbiota in mice model
. Front Nutr
. 2022
;9
:972569
. 49.
Pan
M
, Wan
C
, Xie
Q
, Huang
R
, Tao
X
, Shah
NP
, et al. Changes in gastric microbiota induced by Helicobacter pylori infection and preventive effects of Lactobacillus plantarum ZDY 2013 against such infection
. J Dairy Sci
. 2016
;99
(2
):970
–81
. 50.
Kaur
B
, Garg
N
, Sachdev
A
, Kumar
B
. Effect of the oral intake of probiotic Pediococcus acidilactici BA28 on Helicobacter pylori causing peptic ulcer in C57BL/6 mice models
. Appl Biochem Biotechnol
. 2014
;172
(2
):973
–83
. 51.
Zhao
K
, Xie
Q
, Xu
D
, Guo
Y
, Tao
X
, Wei
H
, et al. Antagonistics of Lactobacillus plantarum ZDY2013 against Helicobacter pylori SS1 and its infection in vitro in human gastric epithelial AGS cells
. J Biosci Bioeng
. 2018
;126
(4
):458
–63
. 52.
She
F-F
, Lin
J-Y
, Liu
J-Y
, Huang
C
, Su
D-H
. Virulence of water-induced coccoid Helicobacter pylori and its experimental infection in mice
. World J Gastroenterol
. 2003
;9
(3
):516
–20
. 53.
Coconnier
MH
, Lievin
V
, Hemery
E
, Servin
AL
. Antagonistic activity against Helicobacter infection in vitro and in vivo by the human Lactobacillus acidophilus strain LB
. Am Soc Microbiol
. 1998
;64
(11
):4573
–80
. 54.
Le Moal
VL
, Fayol-Messaoudi
D
, Servin
AL
. Compound(s) secreted by Lactobacillus casei strain Shirota YIT9029 irreversibly and reversibly impair the swimming motility of Helicobacter pylori and Salmonella enterica serovar Typhimurium, respectively
. Microbiology
. 2013
;159
(Pt 9
):1956
–71
. 55.
El-Adawi
H
, El-Sheekh
M
, Khalil
M
, El-Deeb
N
, Hussein
M
. Lactic acid bacterial extracts as anti-Helicobacter pylori: a molecular approach
. Ir J Med Sci
. 2013
;182
(3
):439
–52
. 56.
Nagata
K
, Inatsu
S
, Tanaka
M
, Sato
H
, Kouya
T
, Taniguchi
M
, et al. The bifidogenic growth stimulator inhibits the growth and respiration of Helicobacter pylori
. Helicobacter
. 2010
;15
(5
):422
–9
. 57.
Kim
T-S
, Hur
JW
, Yu
MA
, Cheigh
CI
, Kim
KN
, Hwang
JK
, et al. Antagonism of Helicobacter pylori by bacteriocins of lactic acid bacteria
. J Food Prot
. 2003
;66
(1
):3
–12
. 58.
Mukai
T
, Asasaka
T
, Sato
E
, Mori
K
, Matsumoto
M
, Ohori
H
. Inhibition of binding of Helicobacter pylori to the glycolipid receptors by probiotic Lactobacillus reuteri
. FEMS Immunol Med Microbiol
. 2002
;32
(2
):105
–10
. 59.
Li
S
, Lu
AP
, Zhang
L
, Li
YD
. Anti-Helicobacter pylori immunoglobulin G (IgG) and IgA antibody responses and the value of clinical presentations in diagnosis of H. pylori infection in patients with precancerous lesions
. World J Gastroenterol
. 2003
;9
(4
):755
–8
. (in eng). 60.
Shukla
S
, Pujani
M
, Agarwal
A
, Pujani
M
, Rohtagi
A
. Correlation of serology with morphological changes in gastric biopsy in Helicobacter pylori infection and evaluation of immunohistochemistry for H. pylori identification
. Saudi J Gastroenterol
. 2012
;18
(6
):369
–74
. (in eng). 61.
Darma
A
, Nugroho
BST
, Yoanna
V
, Sulistyani
I
, Athiyyah
AF
, Ranuh
RG
, et al. Comparison of Helicobacter pylori stool antigen, salivary IgG, serum IgG, and serum IgM as diagnostic markers of H. pylori infection in children
. Iran J Microbiol
. 2019
;11
(3
):206
–11
. (in eng).62.
Takagi
A
, Yanagi
H
, Ozawa
H
, Uemura
N
, Nakajima
S
, Inoue
K
, et al. Effects of lactobacillus gasseri OLL2716 on Helicobacter pylori -associated dyspepsia: a multicenter randomized double-blind controlled trial
. Gastroenterol Res Pract
. 2016
;2016
:7490452
–6
. 63.
Francavilla
R
, Lionetti
E
, Castellaneta
SP
, Magistà
AM
, Maurogiovanni
G
, Bucci
N
, et al. Inhibition of Helicobacter pylori infection in humans by Lactobacillus reuteri ATCC 55730 and effect on eradication therapy: a pilot study
. Helicobacter
. 2008
;13
(2
):127
–34
. 64.
Ushiyama
A
, Tanaka
K
, Aiba
Y
, Shiba
T
, Takagi
A
, Mine
T
, et al. Lactobacillus gasseri OLL2716 as a probiotic in clarithromycin-resistant Helicobacter pylori infection
. J Gastroenterol Hepatol
. 2003
;18
(8
):986
–91
. 65.
Pinchuk
IV
, Bressollier
P
, Verneuil
B
, Fenet
B
, Sorokulova
IB
, Mégraud
F
, et al. In vitro anti- Helicobacter pylori activity of the probiotic strain Bacillus subtilis 3 is due to secretion of antibiotics
. Antimicrob Agents Chemother
. 2001
;45
(11
):3156
–61
. 66.
Kim
S-M
, Lee
K-H
, Lee
N-K
, Kim
C-J
, Kim
C-H
, Paik
H-D
. Antagonistic activity of Polyfermenticin SCD against Helicobacter pylori KCTC 2948
. J Microbiol Biotechnol
. 2004
;14
(1
):148
–52
.67.
Rezaee
P
, Kermanshahi
RK
, Falsafi
T
. Antibacterial activity of lactobacilli probiotics on clinical strains of Helicobacter pylori
. Iran J Basic Med Sci
. 2019
;22
(10
):1118
–24
. 68.
Rokka
S
, Pihlanto
A
, Korhonen
H
, Joutsjoki
V
. In vitro growth inhibition of Helicobacter pylori by lactobacilli belonging to the Lactobacillus plantarum group
. Lett Appl Microbiol
. 2006
;43
(5
):508
–13
. 69.
Nam
H
, Ha
M
, Bae
O
, Lee
Y
. Effect of Weissella confusa strain PL9001 on the adherence and growth of Helicobacter pylori
. Appl Environ Microbiol
. 2002
;68
(9
):4642
–5
. 70.
De Korwin
J-D
. Advantages and limitations of diagnostic methods for H. pylori infection
. Gastroenterol Clin Biol
. 2003
;27
(3 Pt 2
):380
–90
.© 2025 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2025
You do not currently have access to this content.
